NL-OMON44612已完成3 期
sing D-Galactose as a food supplement in Congenital Disorders of Glycosylation (CDG) - Using Galactose in CDG
Z Leuven0 个研究点目标入组 1 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- 入组人数
- 1
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 2 至 11（—）
入选标准
- •Patient is younger than 21 years old
- •Patient has a biochemically and genetically proven Congenital Disorders of Glycosylation.
- •No galactose intake last 6 weeks
排除标准
- •Patient has any of the following conditions:
- •Aldolase B deficiency
- •Galactosemia
- •Hemolytic uremic syndrome
- •Severe anemia
- •Diagnosis of intellectual disability or developmental delay
- •Galactose Intolerance
研究者
相似试验
已完成
不适用
Using D-Galactose as a Food Supplement in Congenital Disorders of GlycosylationCongenital Disorders of GlycosylationNCT02955264Tulane University8
招募中
不适用
Polydextrose and Soluble Gluco Fiber as a dietetic aid to reduce the risk of type 2 diabetes mellitus.NL-OMON35063niversiteit Maastricht60
尚未招募
2 期
Effect and safety of the nutritional supplement Diamel Oral Solution® compared with placebo, in patients with diabetic macular edema without involvement of the macular center, treated or not with laser. Phase IIRPCEC00000447Catalysis Laboratories, SL.160
尚未招募
Unknown
diagnosis of invasive fungal infectionsCTRI/2023/07/055119Max Super Speciality Hospital
Unknown
2 期
SENeGal SYNbiotic (SENGSYN) StudyPACTR202102689928613iverpool School of Tropical Medicine708